
valganciclovir oral brand names and other generic formulations include:
doxorubicin, pegylated liposomal iv brand names and other generic formulations include:
Doxil IV, Lipodox 50 IV, Lipodox IV
valganciclovir oral and doxorubicin, pegylated liposomal iv
valganciclovir oral increases toxicity of doxorubicin, pegylated liposomal iv by added drug effects. Combination may impair white blood cell development (myelosuppression).
valganciclovir oral and doxorubicin, pegylated liposomal iv
valganciclovir oral increases toxicity of doxorubicin, pegylated liposomal iv by pharmacodynamic synergism. Inreased risk of myelosuppression.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant